Champions Oncology Sponsoring Tumor Models 2015
Hackensack, NJ – July 21, 2015 – Champions Oncology, Inc. (OTC : CSBR) a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced sponsorship of Tumor Models 2015 . The event enables the preclinical and translational oncology community to come together and uncover emerging next generation models that will enhance their drug development strategies.
A discussion on Champions’ PDX-Directed Program for Clinical Advancement will be presented by Neal Goodwin, PhD, Vice President, Corporate Research & Development on Wednesday, July 22. Delegates can also visit the Champions Oncology booth to learn more about the Champions TumorGraft® database of patient-derived xenograft (PDX) models. Detailed information, including indication, clinical data, patient treatment history, and molecular characteristics such as mutations, gene expression, copy number variation or gene fusion, can be queried to identify the best PDX model for research initiatives.
The meetings takes place July 22-23, 2015 in Boston, MA.